Capillary nano-immunoassay for Akt 1/2/3 and 4EBP1 phosphorylation in acute myeloid leukemia

BACKGROUND: Overall cure rates in acute myeloid leukemia (AML) continue to range between 60-65% with disease relapse being a major cause of mortality. The PI3K-Akt-mTOR kinase pathway plays a vital role in pro-survival signals within leukemic cells and inhibition of this pathway is being investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabnis, Himalee, Bradley, Heath L, Bunting, Silvia T, Cooper, Todd M, Bunting, Kevin D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080754/
https://www.ncbi.nlm.nih.gov/pubmed/24923301
http://dx.doi.org/10.1186/1479-5876-12-166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080754/
https://www.ncbi.nlm.nih.gov/pubmed/24923301
http://dx.doi.org/10.1186/1479-5876-12-166

Ejemplares similares